cbdMD, Inc. announced its financial results for the second quarter of fiscal year ended March 31, 2025, on May 15, 2025. The company reported revenue of $4.8 million for the quarter, an increase from $4.3 million in the prior year period, demonstrating continued year-over-year improvements.
The operating loss significantly narrowed from $1.5 million to $0.48 million, reflecting disciplined expense management and early traction from new growth initiatives. These results build on the positive momentum from the first fiscal quarter of 2025.
Ronan Kennedy, CEO and CFO, confirmed the successful completion of the Series A Preferred Stock conversion on May 7, 2025, which added nearly $7 million to the company's equity base. This action, converting $6.7 million of accrued and future dividends, enabled cbdMD to exceed the $4 million minimum NYSE American continued listing standard, resulting in a clean balance sheet with zero debt and a simplified capital structure.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.